All lobbying filings

W STRATEGIES, LLC

Lobbying for ABBOTT LABORATORIES · A pharmaceuticals health care company.

Filing Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Bills named in this filing 1

HR 2300
To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other pu…

Lobbying activity 1

Health Issues

Issues related to infant formula access. H.R.2300 - To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.